methanesulfonyl fluoride has been researched along with Dementia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berlanga, P; Hagan, MM; Ishida, C; Moss, DE; Sandoval, H | 1 |
1 trial(s) available for methanesulfonyl fluoride and Dementia
Article | Year |
---|---|
Methanesulfonyl fluoride (MSF): a double-blind, placebo-controlled study of safety and efficacy in the treatment of senile dementia of the Alzheimer type.
Topics: Acetylcholinesterase; Administration, Oral; Adult; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Palliative Care; Sulfones; Treatment Outcome | 1999 |